Real-World Comparison of Effectiveness, Treatment Persistence, and Safety of First-Line Advanced Therapies at 1 Year for Ulcerative Proctitis
Inflammatory Bowel Diseases · 10.04.2025 · 31 (4) · 1174-1177
DOI: 10.1093/ibd/izae215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 19.09.2024. Verfasst von Rahul S Dalal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Brigham and Women's Hospital Faculty Career Development Award, Brigham and Women’s Hospital Faculty Career Development Award.
Abstract (Originalsprache)
Lay Summary In this retrospective cohort study, vedolizumab was associated with higher odds of steroid-free clinical remission at 1 year compared to anti-TNF agents for bio-naïve patients with ulcerative proctitis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Rahul S Dalal, Jessica R Allegretti
Förderung
- Brigham and Women's Hospital Faculty Career Development Award
- Brigham and Women’s Hospital Faculty Career Development Award
Zitieren
APA
Dalal, R. S., Clarke, L. M., Carlin, A., Cabral, H., & Allegretti, J. R. (2025). Real-World Comparison of Effectiveness, Treatment Persistence, and Safety of First-Line Advanced Therapies at 1 Year for Ulcerative Proctitis. Inflammatory Bowel Diseases, 31(4), 1174-1177. https://doi.org/10.1093/ibd/izae215
Vancouver
Dalal RS, Clarke LM, Carlin A, Cabral H, Allegretti JR. Real-World Comparison of Effectiveness, Treatment Persistence, and Safety of First-Line Advanced Therapies at 1 Year for Ulcerative Proctitis. Inflammatory Bowel Diseases. 2025;31(4):1174-1177. doi:10.1093/ibd/izae215
BibTeX
@article{Dalal2025,
author = {Dalal, Rahul S and Clarke, Lindsay M and Carlin, Alex and Cabral, Heidy and Allegretti, Jessica R},
title = {Real-World Comparison of Effectiveness, Treatment Persistence, and Safety of First-Line Advanced Therapies at 1 Year for Ulcerative Proctitis},
journal = {Inflammatory Bowel Diseases},
year = {2025},
volume = {31},
number = {4},
pages = {1174--1177},
doi = {10.1093/ibd/izae215}
}
EUVIMED